Eli Lilly, a big drug company, said on September 1, 2025, that the price of Mounjaro (tirzepatide) would go up a lot at all UK pharmacies.
The price of this life-changing drug went up overnight, sometimes by more than 150%, depending on how strong the dose was.

This sudden rise shocked thousands of private users who used Mounjaro to help them lose weight and keep their Type 2 diabetes under control.
The company said the rise was because of “price alignment across global markets”, but for patients who were already having trouble making ends meet, it felt more like corporate greed than a fair market correction.

Patients of the NHS are still safe because of fixed supply contracts.
However, private users who buy from places like Boots, Lloyds, and independent online pharmacies have seen their monthly costs go through the roof.

During this crisis, GLP JOURNEY has stepped up with a fair-price alternative:
Tirzepatide and Retatrutide pens that have the same active ingredients and therapeutic effects but cost up to 200% less.

This article explains why the price of Mounjaro went up, what it means for patients, and how GLP JOURNEY’s low-cost approach is changing how metabolic health is handled in the UK.

What Happened to the Cost of Mounjaro in the UK?

Since it came out in the UK, Mounjaro has been called a medical breakthrough.
It works great for people with Type 2 diabetes and for people who want to lose weight in a healthy way that lasts.
The drug works by turning on both GLP-1 and GIP receptors.
This makes you less hungry, keeps your blood sugar levels stable, and helps you lose weight faster.

But because it worked so well, demand shot up in 2025.
Pharmacies couldn’t keep up.
The waiting lists grew longer every month.
Eli Lilly said that “supply constraints” were to blame, and they changed the prices a lot on September 1, 2025, to match prices in Europe.

This meant that the prices of Mounjaro in stores went up by 45% to 170%, depending on how strong it was:

• With lower doses, there were moderate increases.

• The biggest spikes were at the higher strengths — 10 mg, 12.5 mg, and 15 mg.

Eli Lilly said the change was about fairness, but most patients thought it was unfair.
The timing couldn’t have been worse.
It happened at the height of a cost-of-living crisis in the UK, when people couldn’t afford the care they needed.

Patients are still safe because of NHS agreements.
But now people who pay for their own pens have to pay between £300 and £370 each, which makes a lot of them decide whether to keep going with their therapy or stop it altogether.

People have started looking for better choices because of this.
They have gone to GLP JOURNEY, a UK-based company that sells the same drug (tirzepatide) for a lot less money.

Prices for Boots Mounjaro in October 2025

Boots, one of the UK’s most trusted pharmacy chains, has changed its prices to match Eli Lilly’s new list prices.
Here are the prices for Boots Mounjaro and GLP JOURNEY Tirzepatide side by side (as of October 2025):

These numbers tell the whole story.
Boots sells a 10 mg Mounjaro pen for £336, but GLP JOURNEY sells the same pen with active tirzepatide for £169.
That means you save almost £170 on each pen, which adds up to more than £2,000 a year for people who use them regularly.

For people who get shots once a week, that difference can mean being able to keep getting treatment without worrying about money, keep making progress, and stay healthy by not missing doses.

Cheap Tirzepatide and Retatrutide Pens from GLP JOURNEY

GLP JOURNEY sells research-grade Tirzepatide pens, which are the same molecule as Mounjaro, but they don’t cost as much as drug companies charge.
Every pen is made to strict standards, so it is always clean, correct, and free of germs.

Tirzepatide works by mimicking natural incretin hormones, which help the body keep blood sugar levels stable and lower hunger.
It works on two receptors, GLP-1 and GIP, which makes it one of the best peptides for losing weight and keeping your metabolism in check.

GLP JOURNEY sells Retatrutide pens in addition to Tirzepatide.
These are the next generation of “triple-agonist” drugs.
Retatrutide works on three different types of receptors: GLP-1, GIP, and glucagon.
This makes it even better at speeding up metabolism and burning fat.

Why People Are Going to GLP JOURNEY

• Prices are as much as 200% lower than at Mounjaro

• Same active ingredient (Tirzepatide) and same results

• Strength choices that match all Mounjaro doses

• UK prices that are clear, with no extra fees or hidden costs

• Fast, private delivery in the UK

• Excellent customer support and service

The only thing GLP JOURNEY wants to do is make the newest metabolic therapy available to everyone.
Its fair-price model makes sure that users can keep up with their treatment without having to worry about money.

GLP JOURNEY helps people get long-term health benefits without spending a lot of money by making things easy to use and learn.

Why Choose GLP JOURNEY Over Mounjaro?

The only things that matter when two products have the same molecule are how much they cost, how ethical they are, and how easy they are to get.

Here are the reasons why thousands of people in the UK are choosing GLP JOURNEY as their main source for Tirzepatide:

1. Same Science, Lower Cost

The Tirzepatide pens from GLP JOURNEY have the same dual GLP-1/GIP receptor agonist as Mounjaro.
The effects on the body are the same — better control of blood sugar, less hunger, and fat loss over time.
What’s the difference? A fair price.

2. Save Up to 200%

The price of most Mounjaro pens has gone up a lot since September.
They now cost between £336 and £372.
GLP JOURNEY has the same benefits for £169–£189, which is a lot less money and works just as well.

3. Long-Term Viability

It takes time to change your health.
You can keep going for months or years if you can afford treatment.
This leads to better results without the financial stress that makes many people stop too soon.

4. Openness in the UK

GLP JOURNEY is based in the UK and has prices that are easy to understand.
No extra fees for clinics, no extra subscriptions, and no middlemen.
Just simple, low-cost access to high-quality peptides.

5. New Ideas for the Future

Retatrutide is a triple-agonist peptide that is expected to work better than Tirzepatide.
GLP JOURNEY is one of the first companies in the UK to offer it.
This gives UK users a head start on the next step in weight loss research.

6. A Community and Real Help

GLP JOURNEY is not like retail pharmacies because it promotes a community based on real progress.
Customers share their results, tips, and success stories, which creates a support network that keeps them going.

People Who Save Real Money

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
I couldn’t believe how different it was!”
— Sarah, Leeds

“I paid almost £300 for my 7.5 mg Mounjaro pen at Boots.
GLP JOURNEY sold it for £159.
Same results, but half the price.”
— James, Manchester

“I paid £350 for the 12.5 mg Mounjaro pen I got from Boots.
GLP JOURNEY charged £179 for it.
It helped me save a lot of money!”
— Chloe, Brighton

More and more of these kinds of stories are coming out in the UK.
People are beginning to realise that they don’t have to sacrifice their health to pay for their medicine.
If you’ve been affected by the recent price hikes for Mounjaro, GLP JOURNEY is the best option because it has clear prices and proven results.

Less Cost = Long-Term Progress

When it comes to metabolic therapy, consistency is very important.
If you don’t take your medicine or miss doses, your appetite may come back, your blood sugar may become unstable, and your progress may stop.

But because of Mounjaro’s new prices, a lot of people have had to skip weeks, stretch out their injections, or stop altogether — undoing months of hard work.

GLP JOURNEY fixes that problem.
As long as the prices are fair, users can stick to a regular dosing schedule.
This helps them lose fat slowly and reset their metabolism for the long term.

Annual Cost Comparison

Total Savings for the Year: £2,012

That’s more than £2,000 saved, which is enough to pay for another full year of therapy or to buy things that will help your health, like exercise and good nutrition.

Affordable care not only saves money — it also keeps results.

Be a Part of the GLP JOURNEY Movement

The rise in Mounjaro prices in September 2025 made a clear problem in the healthcare market:
Patients shouldn’t have to choose between being healthy and being able to pay their bills.

GLP JOURNEY has filled that gap with a fair, clear, and simple answer.
Patients can keep going on their metabolic journey without any problems because of how it prices its services.

When you buy a GLP JOURNEY pen, you’re not just saving money; you’re also joining a movement that wants to use science and openness to make health outcomes better.

A Quick Look at the Main Benefits

• Costs up to 200% less than branded Mounjaro

• Same molecule of Tirzepatide, same effects

• Optional Retatrutide pens to help you lose more weight

• Prices in the UK that are clear and fair

• Trusted community support

• Fast UK delivery and easy reordering

You are in charge of your health, your money, and your progress.
Getting healthier doesn’t have to cost a lot of money with GLP JOURNEY.

Questions and Answers

Q: Why did Mounjaro prices go up in 2025?
Eli Lilly raised prices in the UK on September 1, 2025, to match prices in Europe.
The increase was between 45% and 170%, and pens with high doses cost more than £350.

Q: Is GLP JOURNEY the same as Mounjaro?
Yes, both have Tirzepatide, which is a drug that works on both GLP-1 and GIP receptors.
The only things that are different are the name and the price. The effects are the same.

Q: Is it okay for me to switch from Mounjaro to GLP JOURNEY?
Yes, of course.
A lot of people don’t have any problems switching over as long as they stick to the same dosage schedule.
Always check with your doctor before changing your dose.

Q: How much cheaper is GLP JOURNEY?
Depending on the dose, GLP JOURNEY is 40% to 200% less expensive.
It costs £336 for a pen from Boots, but £169 for one from GLP JOURNEY.

Q: What is Retatrutide, and how does it stack up?
Retatrutide is a new peptide that works on the receptors for GLP-1, GIP, and glucagon.
It helps you burn fat and use energy better than Tirzepatide.
You can get a head start on research on this new compound with GLP JOURNEY.

Q: Is GLP JOURNEY located in the UK?
Yes, GLP JOURNEY is based in the UK and does business with people in the UK and the EU.
Everything is sent out quickly, safely, and without making a fuss.

Q: Do you check the quality of the GLP JOURNEY products?
Yes. Every pen is made to strict research-grade standards that make sure it is clean, pure, and correct.

Q: Do I need a prescription?
You can only buy GLP JOURNEY pens for research.
If you want prescribed therapy, you should see a doctor.

A lot of patients in the UK think they can’t get better because Mounjaro’s price went up in 2025.
Therapy that used to be easy to get is now only available to those who can pay for it.

But there is another option.

GLP JOURNEY offers a research-grade solution with the same active ingredient that is cheaper and has clear pricing.
You can save as much as 200%.

This is the better choice for people who want to keep their metabolism healthy in the long term without having to pay a lot for drugs.

“Boots wanted £336 for my 10 mg Mounjaro pen, but GLP JOURNEY only charged £169.
What a big change.”
— Sarah, Leeds

The message is clear: why pay more for the same molecule?

Join the thousands of others who have already switched and make your GLP JOURNEY one of progress, confidence, and low cost.